|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:BSE_code
|
532488
|
|
gptkbp:country
|
gptkb:India
|
|
gptkbp:founded
|
1990
|
|
gptkbp:founder
|
Murali K. Divi
|
|
gptkbp:headquarters_location
|
gptkb:Hyderabad
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Divi's Laboratories
|
|
gptkbp:industry
|
Pharmaceuticals
|
|
gptkbp:ISIN
|
INE361B01024
|
|
gptkbp:keyPerson
|
gptkb:Madhusudhan_Rao
Kiran S. Divi
Murali K. Divi
|
|
gptkbp:location
|
gptkb:Andhra_Pradesh
gptkb:Telangana
|
|
gptkbp:manufacturingFacilities
|
gptkb:Hyderabad
gptkb:Visakhapatnam
|
|
gptkbp:marketCap
|
over $10 billion (2023)
|
|
gptkbp:netIncome
|
₹1,383 crore (FY 2022-23)
|
|
gptkbp:NSE_symbol
|
DIVISLAB
|
|
gptkbp:numberOfEmployees
|
over 16,000
|
|
gptkbp:products
|
Active pharmaceutical ingredients
Intermediates
|
|
gptkbp:publiclyTraded
|
Yes
|
|
gptkbp:revenue
|
₹7,033 crore (FY 2022-23)
|
|
gptkbp:servesArea
|
Worldwide
|
|
gptkbp:stockExchange
|
gptkb:NSE
BSE
|
|
gptkbp:subsidiary
|
Divi's Laboratories Europe AG
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:website
|
https://www.divislabs.com/
|
|
gptkbp:bfsParent
|
gptkb:S&P_BSE_SENSEX
|
|
gptkbp:bfsLayer
|
7
|